PropertyValue
?:definition
  • Molecular assay reagents intended to identify genetic variants associated with altered patient response to cardiovascular pharmaceuticals (e.g., antithrombotics). Genetic variants at multiple loci have been associated with altered pharmacokinetics or pharmacodynamics of cardiovascular pharmaceuticals. These reagents are intended to detect various types of genetic changes (e.g., deletions, duplications, insertions, substitutions) in multiple cardiovascular pharmacogenetic loci simultaneously.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C4287267_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C4287267_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all